This startup wants to build a needle-free CGM using nanotechnology
Graphwear recently raised $20.5 million, which it plans to use to develop a CGM that uses nanotechnology to measure blood glucose levels.
Mammoth Biosciences raises $45M Series B round for CRISPR diagnostics, therapeutics development
The latest round of funding, led by Chinese investors, brings the total amount of money raised by the company, co-founded by CRISPR pioneer Jennifer Doudna, to more than $70 million.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Mission Bio raises $30M in Series B round to develop genomics platform
The company said it would use the funding to expand its single-cell DNA sequencing platform into CRISPR applications and global markets.
Nebula Genomics raises $4.3M in seed capital to fund blockchain-based data marketplace
The company plans to use blockchain and other technologies to develop the genomic data marketplace, under a partnership with Veritas Genetics.